TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tidal volume improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sense of dyspnea reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attention Network Test accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine N-acetyl-beta-D-glucosaminidase (NAG index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rates of functional independence (mRS score 0-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDAEP alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse of diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Fecal bifidobacteria levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of reactions to platelet transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of severe reactions to platelet transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: willingness to seek help
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: social stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decline in neuropsychological functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Continuing care calls completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difficulty reading small print
Endpoint domain: Life impact
Endpoint subdomain: Visual functioning
Primary endpoint: Difficulty doing fine work
Endpoint domain: Life impact
Endpoint subdomain: Visual functioning
Primary endpoint: Difficulty watching television
Endpoint domain: Life impact
Endpoint subdomain: Visual functioning
Primary endpoint: Mean OSDI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demodex presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in knee pain while walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in response to therapy (patients' global assessment)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of response according to OMERACT-OARSI criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak serum creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnostic accuracy for clinically significant PCa detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Visual function benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission of study entry lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of new lesions
Endpoint domain: Adverse events/effects
Primary endpoint: Fat absorption improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Protein absorption improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 6MWA distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of Frey syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative incidence of facial contour apparent deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impairment in concentration, memory, and executive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Zarit Burden Interview (ZBI) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lower urinary tract function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: bioequivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response (CR) rate after concurrent chemoradiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial Response (PR) rate after induction chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rates of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: CEPI-CT prolongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sTXB2 level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional deficit in the autoregulation of retinal arterioles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: incidence of postoperative vomiting (POV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in speed of processing abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Participants' ratings of overall abilities to remember
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cmax of unchanged nebivolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for unchanged (+/‐)‐nebivolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for (+)‐nebivolol plus its hydroxylated metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for (‐)‐nebivolol plus its hydroxylated metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total hours employed over 18 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in HDL‐carried miRNA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of the MDDScore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall accuracy of the MDDScore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: resistive index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Likelihood to recommend the physician
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 5-year survival benefit
Endpoint domain: Mortality/survival
Primary endpoint: Severe hypersensitivity reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Postanesthetic recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative emesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported desire to consume additional alcohol beverages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental Shuttle Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemia-driven target lesion revascularization (TLR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Compliance with referral recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Assessment of neonates within 2 days of birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma IGF‐I concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-adjusted life-years gained
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative risk of IN RAM after 96 weeks of follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain scores while coughing (AUC/24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median morphine consumption (0-2 hours postoperatively)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Parental understanding of surgical risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NEI‐VFQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NIH-CPSI score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: New clinically unrecognized vertebral fractures
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects having S.25(OH)D levels >20 ng/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean percentage change in S.25(OH)D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: grade 4 neutropaenia
Endpoint domain: Adverse events/effects
Primary endpoint: grade 3-4 stomatitis
Endpoint domain: Adverse events/effects
Primary endpoint: grade 3-4 infection
Endpoint domain: Adverse events/effects
Primary endpoint: reconsultation rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: High-Sensitivity C-Reactive Protein (hs-CRP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: urethral catheter obstruction
Endpoint domain: Adverse events/effects
Primary endpoint: urine retention
Endpoint domain: Adverse events/effects
Primary endpoint: ACE-mRNA transcripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade ≥III gastrointestinal toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intention to complete and return the FIT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal cancer screening knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal cancer screening uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of rheumatoid factor (RF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of hGRalpha and hGRbeta mRNA expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in fibrinogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HC VA (High Contrast Visual Acuity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LC logMAR VA (Low Contrast Logarithmic Visual Acuity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for objective vs subjective refraction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity and specificity of capsule endoscopy in detecting esophageal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: BMD measurement or osteoporosis medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinician-reported outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Fatigue Inventory‐20 general fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of genital epithelial disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean elapsed time for radial artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfactory blood pressure monitoring and sampling of blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall rate of complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: IIEF EF domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in spinal BMD z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in height z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary albumin-to-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Levels of CSF Abeta42
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of CSF tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dry eye assessed by TFBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LTMH (Lacrimal Tear Meniscus Height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased implementation planning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in inappropriate shocks delivered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nutrient-dense food consumption frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epworth sleepiness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of wakefulness test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to quit
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual field loss severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative TL damage incidence
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of ischemic stroke risk
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of bleeding cases
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of platelet activation markers (CD62p and CD63)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of chemokine RANTES
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weekly drop seizure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximal fall in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Recovery times after dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Procedural stroke or death risk
Endpoint domain: Mortality/survival
Primary endpoint: NEI VFQ‐25 composite score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Low-density lipoprotein cholesterol (LDL) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall procedure satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Objective and subjective cure rates
Endpoint domain: Mortality/survival
Primary endpoint: Successful stent implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: No major adverse cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Overall procedural times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total anti-oxidant capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated intra‐operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effectiveness of fospropofol in providing general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient burning sensation as an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Asthma severity ratings reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of fatal or non-fatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Minnesota Living With Heart Failure (MLWHF) scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Resting HR<70/min achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to development of moderate or severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-VAS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: gamma-GT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: alcohol intake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24-hour blood drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total units of packed red blood cells received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: global skin appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: surface texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skin tightening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: AD transformation rate
Endpoint domain: Mortality/survival
Primary endpoint: Fasting plasma TAG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of pregnancy health care
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: self-efficacy in pregnancy health care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: practice behavior in pregnancy health care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Operational failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with CACFP standards
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal sodium excretion (FeNa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean urine sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nocturnal hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in Global:Restless/impulsive subscale of CRS‐P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Parent impact‐emotional (PE) subscale of the CHQ
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in ADHD-Index and hyperactive components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade of fatty liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: serum glucose indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systolic Blood Pressure (SBP) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: myoma recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of ACS based on radiation of pain to the right arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost to avoid one treatment failure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CAP-related hospitalization rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total CAP-related hospitalization costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in motivational interviewing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxidized-LDL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PCSK9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of anal intraepithelial neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of grade 2 or 3 anal intraepithelial neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Risk of persistent anal infection with HPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cough severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in manifestations of actinic damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: graft take-up rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of retraction of neotympanum
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative air-bone gap gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes